Oragenics Targets Brain Health Expansion with CNS Acquisition Plans Amid Progress in ONP-002 Trials
Market Chameleon (Thu, 12-Mar 11:45 AM)
Oragenics Advances Concussion Drug Trial and Explores CNS Asset Acquisitions
at www.tipranks.com (Wed, 11-Mar 9:49 PM)
